Related references
Note: Only part of the references are listed.Filgrastim, fibrinolysis, and neovascularization
Darwin Eton et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2022)
Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
Panagiotis Theofilis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association
Michael H. Criqui et al.
CIRCULATION (2021)
Inflammatory Mechanisms Contributing to Endothelial Dysfunction
Panagiotis Theofilis et al.
BIOMEDICINES (2021)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study
Anurag Mehta et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Vascular Regeneration in Peripheral Artery Disease
John P. Cooke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome
Hekmat B. Khoukaz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease
J. Aaron Barnes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications
Evangelos Oikonomou et al.
ATHEROSCLEROSIS (2020)
Therapeutic effects of coronary granulocyte colony-stimulating factor on rats with chronic ischemic heart disease
Pengcheng Ren et al.
OPEN LIFE SCIENCES (2020)
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis
Peige Song et al.
LANCET GLOBAL HEALTH (2019)
The effect of pegylated granulocyte colony-stimulating factor on collateral function and myocardial ischaemia in chronic coronary artery disease: A randomized controlled trial
Tobias Traupe et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2019)
Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease
Christoph Edlinger et al.
HEART AND VESSELS (2019)
Vildagliptin and G-CSF Improved Angiogenesis and Survival after Acute Myocardial Infarction
Mincai Li et al.
ARCHIVES OF MEDICAL RESEARCH (2019)
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans et al.
EUROPEAN HEART JOURNAL (2018)
Outcome From a Randomized Controlled Clinical Trial - Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT) -
Takashi Horie et al.
CIRCULATION JOURNAL (2018)
Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions
Jessica Cavalcante dos Santos et al.
CLINICS (2018)
Clinical Assessment of Peripheral Arterial Disease of the Lower Limbs
Peter Gogalniceanu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial
Takayasu Ohtake et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
William Herrington et al.
CIRCULATION RESEARCH (2016)
Epidemiology of coronary heart disease and acute coronary syndrome
Fabian Sanchis-Gomar et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: A double-blind, randomized, placebo-controlled clinical trial
Yo Iwata et al.
AMERICAN HEART JOURNAL (2013)
Plasminogen Activator Inhibitor-1 Levels and Activity Decrease After Intervention in Patients with Critical Limb Ischaemia
M. Bjorck et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2013)
Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia
Qingbin Zhao et al.
JOURNAL OF CARDIOLOGY (2013)
Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin
Paul J. Declerck et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Nitrosative stress and redox-cycling agents synergize to cause mitochondrial dysfunction and cell death in endothelial cells
Anne R. Diers et al.
REDOX BIOLOGY (2013)
Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia
Makoto Kinoshita et al.
ATHEROSCLEROSIS (2012)
Granulocyte Colony-Stimulating Factor Improves Cerebrovascular Reserve Capacity by Enhancing Collateral Growth in the Circle of Willis
Andre Duelsner et al.
CEREBROVASCULAR DISEASES (2012)
Acute Myocardial Infarction Caused by Filgrastim: A Case Report
Cemil Bilir et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE (2012)
The Role of Endothelial Progenitor Cells in Vascular Repair after Arterial Injury and Atherosclerotic Plaque Development
Alexandros Briasoulis et al.
CARDIOVASCULAR THERAPEUTICS (2011)
Treatment of Leg Ischemia With Biodegradable Gelatin Hydrogel Microspheres Incorporating Granulocyte Colony-stimulating Factor
Itta Kawamura et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Granulocyte Colony-Stimulating Factor Enhances Arteriogenesis and Ameliorates Cerebral Damage in a Mouse Model of Ischemic Stroke
Yukio Sugiyama et al.
STROKE (2011)
Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction
Birgit A. Steppich et al.
THROMBOSIS RESEARCH (2011)
Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia
Mohammad Reza Zafarghandi et al.
CYTOTHERAPY (2010)
BCL-2: pro-or anti-oxidant?
Zhi Xiong Chen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Granulocyte-macrophage colony-stimulating factor gene based therapy for acute limb ischemia in a mouse model
Chester Bittencourt Sacramento et al.
JOURNAL OF GENE MEDICINE (2009)
Intramuscular Transplantation of G-CSF-Mobilized CD34+ Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single-Blinded, Dose-Escalation Clinical Trial
Atsuhiko Kawamoto et al.
STEM CELLS (2009)
Angiogenesis achieved by granulocyte colony-stimulating factor in combination with bypass surgery in 2 cases of critical limb ischemia
Mitsuyuki Nakayama et al.
CIRCULATION JOURNAL (2008)
G-CSF treatment after myocardial infarction: Impact on bone marrow-derived vs cardiac progenitor cells
Stefan Brunner et al.
EXPERIMENTAL HEMATOLOGY (2008)
Treatment with granulocyte colony stimulating factor is associated with improvement in endothelial function
Ignatios Ikonomidis et al.
GROWTH FACTORS (2008)
Granulocyte colony-stimulating factor - A noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease
Masazumi Arai et al.
CIRCULATION JOURNAL (2006)
PAI-1 and atherothrombosis
DE Vaughan
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Circulating endothelial adhesion molecules (sE-selectin, sVCAM-1 and sICAM-1) during rHuG-CSF-stimulated stem cell mobilization
T Südhoff et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2002)
Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant C-CSF
O Arslan et al.
CYTOTHERAPY (2000)
Share Paper
